Comparison of inflammatory response following coronary revascularization with or without cardiopulmonary bypass

Experimental and Clinical Cardiology

Volumn 9, Issue 1, 2004, Pages 26-30

  Gasz, Balázs ^a   Benkö, László ^a   Jancsó, Gb́or ^a   Lantos, János ^a   Szátó, Zalán ^a   Alotti, Nasri ^b   Röth, Erzsébet ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Zala Country Hospital   (Hungary)

Author keywords

Adhesion molecule; Cardiopulmonary bypass; Coronary bypass; Cytokines

Indexed keywords

CD11 ANTIGEN; CD18 ANTIGEN; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; FEMALE; FLOW CYTOMETRY; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LEUKOCYTE; LEUKOCYTE COUNT; MALE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 2942661467     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest 1997;112:676-92.
2. Wan S, LeClerc JL, Vincent JL. Cytokine response to cardiopulmonary bypass: Lessons learned from cardiac transplantation. Ann Thorac Surg 1997;116:269-76.
3. Wan S, Anthony PC. Cytokines in myocardial injury: Impact on cardiac surgical approach. Eur J Cardiothorac Surg 1999;16:107-11.
4. Jerrold H, Kenichi A. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;59:715-20.
5. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
6. Schwartz JD, Shamamian P, Schwartz DS, et al. Cardiopulmonary bypass primes polymorphonuclear leukocytes. J Surg Res 1998;75:177-82.
7. Craddock PR, Hammerschmidt D, White JG, Dalmosso AP, Jacob HS. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest 1977;60:260-4.
8. Redl H, Schlag G, Kneidinger R, Dinges HP, Davies J. Activation/adherence phenomena of leukocytes and endothelial cells in trauma and sepsis. In: Schlag G, Redl H, eds. Pathophysiology of Shock, Sepsis, and Organ Failure. Berlin: Springer-Verlag, 1993:549-63.
9. Buffolo E, de Andrade CS, Branco JN, Teles CA, Aguiar LF, Gomes WJ. Coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg 1996;61:63-6.
10. Benetti FJ, Naselli G, Wood M, Geffner L. Direct myocardial revascularization without extracorporeal circulation. Experience in 700 patients. Chest 1991;100:312-6.
11. Norton JA, Bollingen RR, Lowry SF, et al, eds. Surgery. Basic Science and Clinical Evidence. Berlin: Springer Verlag, 2000:1335-8.
12. Strüber M, Cremer JT, Gohrbandt B, et al. Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg 1999;68:1330-5.
13. Olthof CG, Jansen PG, de Vries JP, et al. Interstitial fluid volume during cardiac surgery measured by means of a non-invasive conductivity technique. Acta Anaesthesiol Scand 1995;39:508-12.
14. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 1987;13:89-95.
15. Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 1994;107:1489-95.
16. Gott JP, Cooper WA, Schmidt FE Jr, et al. Modifying risk for extracorporeal circulation: Trial of four antiinflammatory strategies. Ann Thorac Surg 1998;66:747-53.
17. Moen O, Hogasen K, Fosse E, et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997;63:105-11.
18. Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 1996;112:494-500.
19. Bucerius J, Gummert JF, Walther T, et al. Predictors of prolonged ICU stay after on-pump versus off-pump coronary artery bypass grafting. Intensive Care Med 2004;30:88-95.
20. Al-Ruzzeh S, Ambler G, Asimakopoulos G, et al; United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome. Off-pump coronary artery bypass (OPCAB) surgery reduces risk-stratified morbidity and mortality: A United Kingdom multi-center comparative analysis of early clinical outcome. Circulation 2003;108(Suppl 1):II1-8.
21. Fransen E, Maessen J, Dentener M, Senden N, Geskes G, Buurman W. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 1998;113:1290-5.
22. Matata BM, Sosnowski AW, Galinanes M. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 2000;69:785-91.
23. Schulze C, Conrad N, Schutz A, et al. Reduced expression of systemic proinflammatory cytokines after off-pump versus conventional coronary artery bypass grafting. Thorac Cardiovasc Surg 2000;48:364-9.
24. Meldrum DR, Cleveland JC Jr, Cain BS, Meng X, Harken AH. Increased myocardial tumor necrosis factor-alpha in crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg 1998;65:439-43.